# New Mountain Finance Corp: overview

NMFC · Nasdaq · CIK 1496099 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nmfc.md) · [Financials](/companies/nmfc/financials.md) · [Filings](/companies/nmfc/filings.md) · [Insiders](/companies/nmfc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.22](/filings/0001496099-25-000035.md) | not reported | [0.22](/filings/0001496099-26-000016.md) | [0.07](/filings/0001496099-26-000029.md) | [0.11](/filings/0001496099-25-000035.md) | not reported | [(0.51)](/filings/0001496099-26-000016.md) | [0.18](/filings/0001496099-26-000029.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.91](/filings/0001496099-24-000012.md) | [0.74](/filings/0001496099-25-000010.md) | [1.24](/filings/0001496099-26-000008.md) | [1.03](/filings/0001496099-26-000008.md) | [0.16](/filings/0001496099-26-000008.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nmfc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $17.8m | 2,477,549 |  | Added +386,273 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $15.4m | 2,145,047 |  | Added +348,872 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $11.2m | 1,557,647 |  | Reduced −582,030 |
| [Russell Investments Group, Ltd.](/funds/1692234.md) | 2026-06-30 | $9.9m | 1,383,171 |  | Added +444,492 |
| [DIMENSION CAPITAL MANAGEMENT LLC](/funds/1041773.md) | 2026-06-30 | $8.8m | 1,223,088 |  | Added +66,547 |
| [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $8.1m | 1,125,657 |  | Added +254,361 |
| [Cerity Partners LLC](/funds/1566475.md) | 2026-06-30 | $6.1m | 856,875 |  | Reduced −15,969 |
| [National Philanthropic Trust](/funds/1785342.md) | 2026-06-30 | $6.1m | 852,921 |  | Unchanged |
| [Muzinich & Co., Inc.](/funds/1618824.md) | 2026-06-30 | $6.1m | 850,170 |  | Added +1,252 |
| [Pathstone Holdings, LLC](/funds/2011612.md) | 2026-06-30 | $5.9m | 824,801 |  | Added +163,582 |

## Recent filings

[All 890 filings](/companies/nmfc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-03 | 16:28 ET | [10-Q](/filings/0001496099-26-000029.md) | Quarterly report, period 2026-06-30 | 0001496099-26-000029 |
| 2026-08-03 | 16:17 ET | [8-K](/filings/0001496099-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001496099-26-000027 |
| 2026-06-18 | 16:05 ET | [8-K](/filings/0001580642-26-003851.md) | 2.03 New direct financial obligation; 8.01 Other events | 0001580642-26-003851 |
| 2026-06-05 | 17:26 ET | [8-K](/filings/0001580642-26-003617.md) | 8.01 Other events | 0001580642-26-003617 |
| 2026-05-15 | 16:16 ET | [8-K](/filings/0001580642-26-003214.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001580642-26-003214 |
| 2026-05-04 | 16:33 ET | [10-Q](/filings/0001496099-26-000016.md) | Quarterly report, period 2026-03-31 | 0001496099-26-000016 |
| 2026-05-04 | 16:23 ET | [8-K](/filings/0001496099-26-000014.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001496099-26-000014 |
| 2026-03-27 | 16:59 ET | [DEF 14A](/filings/0001140361-26-011780.md) | Proxy statement, period 2026-05-12 | 0001140361-26-011780 |
| 2026-03-24 | 16:30 ET | [8-K](/filings/0001580642-26-001977.md) | 5.02 Departure or appointment of officers or directors | 0001580642-26-001977 |
| 2026-03-13 | 17:11 ET | [8-K](/filings/0001580642-26-001812.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001580642-26-001812 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001496099-26-000008.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1496099
- Tickers: NMFC, NMFCZ
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: X1
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:02 ET. No prices; not investment advice.